| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |